BackMarinus Pharmaceuticals Overview

Marinus Pharmaceuticals Current Assets

Marinus Pharmaceuticals's current assets is $57M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$57.40M
70.57% YoYΔ $-137.64M vs prior year quarter

Peer average

Loading

Marinus Pharmaceuticals Current Assets History

Loading

Marinus Pharmaceuticals vs. peers: Current Assets Comparison

Loading

Marinus Pharmaceuticals Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Marinus Pharmaceuticals (MRNS) FAQ

As of the most recent data (September 2024), MRNS shows a current assets of $57M. That compares with $200M in the prior-year period — down 70.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MRNS's current assets is now $57M (was $200M) — a 70.6% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Marinus Pharmaceuticals is outperforming or lagging.

Tracking MRNS's current assets over time shows whether Marinus Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $57M That compares with $200M in the prior-year period — down 70.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Marinus Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $57M) with ownership activity and broader fundamentals.

Marinus Pharmaceuticals's current assets is $57M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.